期刊文献+

不同药物对COPD大鼠Clara细胞和CC16表达的影响 被引量:3

Effects of Different Drugs on the Number of Clara Cells and CC16 in Rat COPD Model
暂未订购
导出
摘要 目的观察N-乙酰半胱氨酸(NAC)、红霉素和地塞米松干预对大鼠慢性阻塞性肺疾病(COPD)模型Clara细胞数量及其分泌蛋白CC16表达的影响。方法单纯熏香烟法建立Wistar大鼠COPD模型。将大鼠随机分为正常对照组、COPD组、NAC组、红霉素组和地塞米松组,每组10只。免疫组织化学方法检测各组大鼠肺组织Clara细胞数量。酶联免疫吸附法检测支气管肺泡灌洗液(BALF)和血清中CC16含量。RT-PCR法检测各组大鼠肺组织中CC16 mRNA的含量。结果COPD组大鼠终末细支管上皮Clara细胞占上皮细胞的百分比明显低于对照组,差异有显著性(P<0.01);NAC组和红霉素组Clara细胞百分比与COPD组相比有所增加(分别为P<0.01,P<0.05);而地塞米松组与COPD组无统计学差异(P>0.05)。COPD组大鼠BALF和血清中CC16蛋白水平(A)明显低于对照组,差异有显著性(P<0.01);NAC组及红霉素组BALF和血清中CC16蛋白水平明显高于COPD组,差异也有显著性(P<0.05);而地塞米松组大鼠BALF和血清中CC16蛋白水平与COPD组比较差异无显著性(P>0.05)。COPD组大鼠肺组织中CC16 mRNA的含量明显低于对照组,NAC干预组和红霉素组明显高于COPD组(分别为P<0.01,P<0.05),而地塞米松组与COPD组比较差异无显著性(P>0.05)。结论被动吸烟所致COPD大鼠的慢性气道炎症可导致Clara细胞数量及CC16的合成及分泌量减少,NAC和红霉素可能通过促进CC16的合成和分泌抑制气道炎症反应,地塞米松对CC16的合成及分泌量未见明显影响。 Objective To investigate the effects of N-acetylcysteine (NAC), erythromycin (ETM) and dexamethasone (DEX) on the number of Clara cells and secretion of Clara cell secretory protein (CC16) in rat chronic obstructive pulmonary disease (COPD) model. Methods Fifty rats were divided into control, COPD, NAC, ETM and DEX groups (n = 1 0). The number of Clara cells was detected by immunohistochemistry. The CC16 level in bronchoalveolar lavage fluid (BALF) and serum was detected by ELISA. The level of CC16 mRNA in the lung was detected by RT-PCR. Results The percentage of Clara cells in terminal bronchioles in the rats of COPD group was significantly lower than that in the control ( P 〈 0.01 ), and the percentages of Clara cells in NAC and ETM groups were significantly higher than that in the COPD group ( P 〈 0.01, P 〈 0.05, respectively). But there was no significant difference between DEX and COPD groups in the percentage of Clara cells. The level of CC16 in the BALF and serum in the COPD group was significantly lower than that in the control group (P 〈 0.01 ) ,and that in NAC and ETM groups were significantly higher than that in the COPD group ( P 〈 0.05). But there was no significant difference between levels of CC16 in BALF and serum in the DEX and COPD groups. The expression of the lung CC16 mRNA in COPD group was weaker than that in the control group, and that in NAC and ETM groups was significantly higher than that in the COPD group (P 〈 0.01, respectively). There was no significant difference between expressions of the lung CC16 mRNA in the DEX and COPD groups (P 〉 0.05 ). Conclusion The number of Clara cells and the secretion of CC16 are reduced in the rat COPD model. NAC and ETM can elevate the synthesis and secretion of CC16, Which may be a mechanism for their suppression of airway inflammation. There is no significant effect of DEX on CC16 in the COPD rat model.
出处 《中国比较医学杂志》 CAS 2008年第2期1-4,F0003,共5页 Chinese Journal of Comparative Medicine
关键词 慢性阻塞性肺疾病 CLARA细胞 CC16 N-乙酰半胱氨酸 红霉素 地塞米松 COPD Clara cells CC16 N-acetylcysteine Erythromycin Dexamethasone
  • 相关文献

参考文献5

二级参考文献23

  • 1吴人亮,李文英,车东媛,王曦,郝春荣.吸烟对小鼠小气道损伤的形态学研究[J].同济医科大学学报,1995,24(5):395-395. 被引量:11
  • 2王曦 吴人亮 等.上皮钙粘附素在吸烟小鼠呼吸道上皮细胞表达的研究[J].中国组织化学与细胞化学杂志,1998,7(3):302-302.
  • 3王曦 李军 等.上皮钙粘附素-连环素复合体的表达与调控的研究进展[J].国外医学:分子生物学分册,1998,20:42-42.
  • 4陈秀銮 李森华.血清中游离羟脯氨酸的测定[J].职业医学,1983,6:19-22.
  • 5王曦,国外医学.分子生物学分册,1998年,20卷,42页
  • 6王曦,中国组织化学与细胞化学杂志,1998年,7卷,302页
  • 7吴人亮,同济医科大学学报,1995年,24卷,395页
  • 8C. Lensmar*,M. Nord,G. H. Gudmundsson,A. Roquet,O. Andersson,H. J?rnvall,A. Eklund,J. Grunewald,B. Agerberth. Decreased pulmonary levels of the anti-inflammatory Clara cell 16 kDa protein after induction of airway inflammation in asthmatics[J] 2000,Cellular and Molecular Life Sciences(6):976~981
  • 9O’ShaughnessyTC,AnsariTW,BarnesNC ,etal.Inflammationinbronchialbiopsiesofsubjectswithchronicbronchitis:inverserelstionshipofCD8+TlymphocyteswithFEV1[].AmJRespirCritCareMed.1997
  • 10Jeffery PK.ComparisonofthestructuralandinflammatoryfeaturesofCOPDandasthmaFilleylecture[].Chest.2000

共引文献267

同被引文献27

  • 1AGUSTI A, SOBRADILLO P, CELLI B. Addressing the com- plexity of chronic obstructive pulmonary disease:from pheno- types and biomarkers to scale-free networks, systems biology, and P4 medicine[ J]. Am J Respir Crit Care Med,2011,183 (9) :1129-1137.
  • 2VALAVANIDIS A,VLACHOGIANNI T, FILTAKIS K. Tobacco smoke:involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles [ J ]. Int J Environ Res Public Heahh,2009,6(2) :445-462.
  • 3BROECKAERT F, BERNARD A. Clara cell secretory protein (CC16) : characteristics and perspectives as lung peripheral biomarker [ J ]. Clin Exp Allergy, 2000,30 ( 4 ) : 469- 475.
  • 4EMURA M. Stem cells of the respiratory tract [ J ]. Paediatr Re- spir Rev,2002,3( 1 ) :36-40.
  • 5MUTTI A, CORRADI M, GOLDONI M, et al. Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma [ J ]. Chest, 2006,129 (5) : 1288-1297.
  • 6BROECKAERT F, BERNARD A. Clara cell secretory protero (CC16) : characteristics and perspectives as lung peripheral biomarker [ J ]. Clin Exp Allergy, 2000,30 ( 4 ) : 469- 475.
  • 7JEFFERY P K. Lymphocytes, chronic bronchitis and chronic obstructive pulmonary disease[J]. Novartis Found Symp,2001, 234 : 149-161 ;discussion 161-168.
  • 8SPIRA A, BEANE J, SHAH V, et al. Effects of cigarette smoke on the human airway epithelial cell transcriptome [ J ]. Proc Natl Acad Sci U S A,2004,101 (27) :10143-10148.
  • 9TILLEY A E ,O'CONNOR T P ,HACKETr N R ,et al. Biolog- ic phenotyping of the human small airway epithelial response to cigarette smoking [ J ]. PloS One,2011,6 (7) : e22798.
  • 10INCORVAIA C, RIARIO- SFORZA G G, PRAVETYONI C, et al. Impairment of small airways' in COPD patients with fre- quent exacerbations and effects of treatment with tiotropium [ J ]. Int J Chron Obstruct Pulmon Dis,2008,3 ( 1 ) :123-126.

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部